JUN and hepatocellular carcinoma: In contrast, AKT, another common hallmark of human HCC, triggers the inhibitory phosphorylation of GSK-3β, leading to increased stability and accumulation of c-MYC and other oncogenes, such as c-JUN and β-catenin [78,79].